Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Home News ArchiveTianshan Material Posts Quarterly Net Loss of RMB 1.65 Billion

Live News EQUITY FLASH M impact Oct 23, 2026, 04:55 PM UTC

Tianshan Material Posts Quarterly Net Loss of RMB 1.65 Billion

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

000877

Related stories

Ionis Partner Roche Reports Sefaxersen Reduced Proteinuria 43.1% in Phase 3 IgAN Study Roche’s Phase 3 study found investigational sefaxersen reduced proteinuria by 43.1% versus placebo at 37 weeks in adults with IgA nephropathy, Ionis reported. M impact | EQUITY | Oct 23, 2026, 05:43 PM UTC Vertex Says Phase 3 RAINIER Trial Meets Primary Endpoint in IgAN Povatacicept cut proteinuria 49.8% versus placebo at Week 36 (P<0.0001) and met both secondary endpoints. Vertex’s FDA BLA for accelerated approval is under review, with a Nov. 30, M impact | EQUITY | Oct 23, 2026, 05:42 PM UTC Selective Insurance Reports Q3 2026 Revenue of $1.33B, EPS of $2.11 Revenue fell 2.5% year over year, while net income available to common stockholders rose 11.8% to $126.4 million. The combined ratio improved to 96.8% from 98.6%. M impact | EQUITY | Oct 23, 2026, 05:41 PM UTC Orchid Island Capital Reports $178.9M Third-Quarter Net Loss Orchid Island Capital reported third-quarter 2026 interest income of $164.1 million, up 51.4% from a year earlier, and a net loss of $178.9 million, or $0.90 per diluted share. It M impact | EQUITY | Oct 23, 2026, 05:41 PM UTC PhillipCapital Upgrades SpaceX to Buy, Sees 70% Upside PhillipCapital reversed its bearish stance and upgraded SpaceX from sell to buy. SpaceX shares gained 1.5% Friday; the body is truncated after referring to its first-ever quarterly M impact | EQUITY | Oct 23, 2026, 05:36 PM UTC Roche Reports Sefaxersen Cut Proteinuria 43.1% in Interim Phase III Data Roche said interim Phase III data showed a statistically significant 43.1% reduction in proteinuria with sefaxersen. L impact | EQUITY | Oct 23, 2026, 05:33 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Market Context
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.